Bedside to Bench

Betting on B cells in multiple sclerosis

Article metrics

A variety of immune cell types contribute to disease in individuals with multiple sclerosis, an autoimmune condition of the central nervous system. Thomas Prod'homme and Scott Zamvil comment on the 'Bench to Bedside' approach, examining how recent basic research implicates the antigen-presenting cell in this disease. In our 'Bedside to Bench' column, Hans Link explores how recent clinical trials may bolster a mechanistic role for the B cell.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Hauser, S.L. et al. N. Engl. J. Med. 358, 676–688 (2008).

  2. 2

    Maloney, D.G. et al. Blood 90, 2188–2195 (1997).

  3. 3

    Cross, A.H., Stark, J.L., Lauber, J., Ramsbottom, M.J. & Lyons, J.-A. J. Neuroimmunol. 180, 63–70 (2006).

  4. 4

    Akiba, H. et al. J. Immunol. 162, 7058–7066 (1999).

  5. 5

    Liossis, S.-N.C. & Sfikakis, P.P. Clin. Immunol. published online, doi: 10.1016/j.clim.2008.0.011 (10 March 2008).

  6. 6

    O'Neill, B.P., Vernino, S., Dogan, A. & Giannini, C. Neuro-oncol. 9, 364–369 (2007).

  7. 7

    Giovannoni, G. & Ebers, G. Curr. Opin. Neurol. 20, 261–268 (2007).

  8. 8

    Serafini, B. et al. J. Exp. Med. 204, 2899–2912 (2007).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading